Revolution Medicines Conference: CEO Details Daraxonrasib Phase III Timeline, First-Line PDAC Push

CEO Mark Goldsmith outlined the company’s late-stage plans for its RAS(ON) inhibitor daraxonrasib, discussed expansion into first-line pancreatic cancer, and offered updates on colorectal cancer and e ...

Apple @ Work: DDM OS Reminder 2.0 fixes the biggest flaw in Declarative Device Management software updates

Apple's native DDM update notifications are too subtle. DDM OS Reminder 2.0 fixes this with prominent, customizable alerts that your users can't miss.